Jul 27, 2020|
JD Health Established its 1st Diabetes Center in Guangdong with Clifford Hospital
by Vivian Yang
On July 24th in Guangzhou, Guangdong province, JD Health and Guangdong Clifford Hospital(广东祈福医院) held the unveiling ceremony of the “Diabetes Intelligent Care Center”, their collaborative project. This center is JD Health’s third official hospital partner and the first partner in Guangdong. It is designed to provide intelligent care assistance to diabetes patients via its comprehensive “internet+healthcare” services.
Guangdong Clifford Hospital is a renowned hospital combining TCM (traditional Chinese medicine) and western medicine. Professor Zhou Minwei, deputy director of Guangdong Clifford Hospital, said that diabetes is closely related to many cardiovascular diseases. The establishment of the intelligent diabetes care center will further expand the scale of patients that the hospital can manage. It will also support the medical staff in the endocrinology department as they explore new treatment models and methods to reduce the occurrence of cardiovascular disease and other complications.
In their partnership, JD Health and Clifford Hospital will, using their respective strengths, create a standardized process for diabetes patients, build customized plans for each patient in terms of diet, exercise, health data monitoring, drug use, etc., and provide targeted care and guidance for patients with cognitive impairments. All the data about the patients will be collected and uploaded through intelligent hardware onto the care center platform where patients’ real-time health reports will be automatically generated. This will help doctors to update and optimize their diagnosis and treatment plans, a process that greatly improves the effectiveness of medical services for the patients while reducing expenses. Additionally, with the integration of online and offline services built by JD Health, patients can purchase medical products and services online and go to offline care centers to use relevant services.
Prior to its official launch, the center has been operating in a trial phase for over a year. Over 300 patients have used the online services during this period and expressed their satisfaction. During COVID-19, drug supplies, blood glucose monitoring, and health management services were not interrupted at all. Instead, the online platform provided timely reminders and regular interactions with patients. This was especially helpful during such an irregular time, particularly to non-local patients.
A lifelong chronic metabolic disease, diabetes takes a long time for doctors to treat and manage. There have been long-existing difficulties such as whole process disease treatment management, real-time patient data monitoring, and rapid adjustment of medical plans depending on changing patient situations. The deployment of the intelligent care center equips endocrinologists with AI-powered tools for easy and real-time integration of online medical consultations, diagnostics, prescriptions, and health management.
Dec 12, 2024|
JD Health Debuts Merck’s New Diabetes Medication GLUCOPHAGE® XR (Reduce Mass) Online in China
On December 10, JD Health, in collaboration with Merck, a globally renowned biopharmaceutical leader, began offering GLUCOPHAGE® XR (Reduce Mass), the metformin hydrochloride extended-release tablets, and became the first online pharmacy in China to provide the new antidiabetic medication developed by Merck. This launch signifies a major milestone in the partnership between JD Health and Merck, which is dedicated to enhancing the online availability and accessibility of innovative treatments for type 2 diabetes patients in China, thereby offering them a more convenient and effective medication experience.
GLUCOPHAGE® has been a cornerstone in the treatment of type 2 diabetes for over 60 years worldwide. The latest version of this medication is designed to enhance patient adherence by reducing the long-term burden of medication administration while maintaining its therapeutic benefits. The use of GSD sustained-release technology extends the time the medication remains in the stomach, reduces gastrointestinal irritation, and improves drug absorption. Additionally, the tablet is now smaller, has reduced volume by 30%, and has been transitioned from a capsule to a round shape, making it easier to swallow. It requires only once-daily administration, significantly enhancing patient convenience and safety.
To celebrate the online launch collaboration, JD Health and Merck hosted a special release event for the new medication at the 7th China International Import Expo in November. This event followed their partnership agreement in September, which also marked the opening of Merck China’s self-operated flagship store on JD.com.
With a large user base, robust supply chain, and rich medical service resources, JD Health has become a preferred partner to launch many chronic disease medications online. By seamlessly integrating online and offline resources, JD Health ensures that new drug information reaches the right users swiftly, offering convenient purchasing options and improving drug accessibility and usage efficiency. Additionally, JD Health’s extensive logistics network ensures timely and secure delivery of medications, enhancing user experience and building trust.
(vivian.yang@jd.com)
JD Will Own 5STAR 100% to Strengthen Omnichannel Presence
